Feasibility and Impact of Resistance Training for Sarcopenic Dysphagia

February 28, 2023 updated by: Tina Hansen, PhD, MSc.OT, Hvidovre University Hospital

Feasibility and Impact of an Activity-based Intervention for Strengthening Ingestive Functions in Elders With Sarcopenic Dysphagia: a Multiple-case Study

The purpose of the study is to test and optimize the feasibility of an activity-based resistance training program for patients with sarcopenic dysphagia. The study is a feasibility study designed as a multiple-case study with quantitative and qualitative data sources related to a number of feasibility outcomes and clinical outcomes during and after the intervention. Participants are 15 patients> 65 years of age are referred for dysphagia assessment by an Occupational Therapist (patients may be admitted to several different wards (endocrinology, pulmonary medicine, infectious medicine, gastrology). The intervention is offered during hospitalization and after discharge for a maximum of 12 weeks.

Study Overview

Study Type

Observational

Enrollment (Actual)

11

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hvidovre, Denmark, 2650
        • Hvidovre University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Participants admitted to an acute hospital for medical reasons (endocrinology, pulmonary medicine, infectious medicine, gastrology), and referred for dysphagia assessment by an Occupational Therapist .

Description

Inclusion Criteria:

  • Speaks and understand Danish language, and able to provide written informed consent for participation
  • Dysphagia verified by a Gugging Swallowing Screen
  • Generalized sarcopenia determined by a Danish version of the questionnaire SARC-F
  • Sarcopenia of the swallowing mechanism indicated by reduced tongue strength measured with the Iowa Oral Performance Instrument

Exclusion Criteria:

  • Dysphagia related to the esophagus
  • Psychiatric diagnosis
  • Neurodegenerative disease or
  • Needs palliative care
  • Admitted to hospital from a nursing home.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intervention tolerance
Time Frame: During two therapy sessions per week in 12 weeks
Time-series of participants rated level of concern for aspiration on a 100 mm VAS-scale ((left side = no concerns and right side = maximal concerns). The success criterion is that 80% of the VAS scales are in the area of 'no concerns' for aspiration.
During two therapy sessions per week in 12 weeks
Adverse effects
Time Frame: During two therapy sessions per week in 12 weeks
Any expected and unintended events during the therapy sessions and the self-training are recorded.
During two therapy sessions per week in 12 weeks
Intervention usefulness
Time Frame: Up to 12 weeks
Participant self-report on the subscale 'Value/usefulness' from the Intrinsic Motivation Inventory (IMI). The subscale covers 7 items to be rated on a 7-point Likert scale (1=Not at all true to 7=very true). A high score indicate high usability.
Up to 12 weeks
Acceptability
Time Frame: Up to 12 weeks
Semi-structured interviews based on the Theoretical Framework of Acceptability
Up to 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emotional wellbeing and global quality of life
Time Frame: Baseline and up to 12 weeks
Two single VAS items using a horizontal line from 0 (worst imaginable emotional well-being / worst imaginable quality of life) to 100 mm (perfect emotional wellbeing /perfect quality of life).
Baseline and up to 12 weeks
Mealtime performance
Time Frame: Baseline and up to 12 weeks
The McGill Ingestive Skills Assessment-version 2 (MISA2). The total score range from 36-108, where higher score indicate higher performance
Baseline and up to 12 weeks
Functional oral intake
Time Frame: Baseline and up to 12 weeks
Functional Oral Intake Scale (FOIS) with a score range of 1( no oral intake) to 7 (Total oral diet with no restrictions).
Baseline and up to 12 weeks
Nutritional status
Time Frame: Baseline and up to 12 weeks
The modified Mini Nutritional Assessment Scale-Short Form (MNA-SF). The total score range from 0 to 14, where a score <8 indicates malnutrition, 8-11 indicates risk of malnutrition, and >11 indicates no malnutrition.
Baseline and up to 12 weeks
Tongue strength and endurance
Time Frame: Baseline and up to 12 weeks
Iowa Oral Performance Instrument (IOPI).
Baseline and up to 12 weeks
Intervention progress _ swallow difficulty
Time Frame: During two therapy sessions per week in 12 weeks.
Self-reported swallowing difficulty of saliva, liquid and food (100 mm VAS scale (left side = no difficulties and right side = unable to swallow).
During two therapy sessions per week in 12 weeks.
Intervention progress_ intensity
Time Frame: During two therapy sessions per week in 12 weeks.
Self-perceived effort from 0 (at rest) to 10 (extremely hard).
During two therapy sessions per week in 12 weeks.
Intervention progress _ Swallow ability
Time Frame: During two therapy sessions per week in 12 weeks.
Records on observed number of successful/unsuccessful swallows.
During two therapy sessions per week in 12 weeks.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demand for the intervention by the target group
Time Frame: Though study completion, an average of three years.
Records of recruitment/attrition rates.
Though study completion, an average of three years.
Intervention functionality
Time Frame: Though study completion, an average of three years.
Records of numbers of complete/incomplete therapy sessions.
Though study completion, an average of three years.
Intervention adaptations
Time Frame: During two therapy sessions per week in 12 weeks.
Records on any adaptations (minor or major modifications, addition of new components, or deletions of a component) in the intervention model of the ACT-ING program during therapy. For any adaptations, 'what', 'how' and 'why' are recorded.
During two therapy sessions per week in 12 weeks.
Determinants for delivering the ACT-ING program by practitioners
Time Frame: Up to 12 weeks.
Semi-structured interview based on the Theoretical Domains Framework
Up to 12 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2020

Primary Completion (Actual)

January 6, 2023

Study Completion (Actual)

February 28, 2023

Study Registration Dates

First Submitted

February 4, 2022

First Submitted That Met QC Criteria

February 25, 2022

First Posted (Actual)

March 8, 2022

Study Record Updates

Last Update Posted (Actual)

March 2, 2023

Last Update Submitted That Met QC Criteria

February 28, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenia

Clinical Trials on activity-based resistance training of ingestive skills (ACT-ING-program)

3
Subscribe